SCHEMBL1176395

SCHEMBL1176395

CC(=O)Nc1ccc(N[C]=O)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.65
▸ SMN1; SMN2 Q16637 3/20 0.61
▸ HTT P42858 1/20 0.61
▸ L3MBTL1 Q9Y468 1/20 0.61
▸ KMT2A Q03164 7/20 0.61
▸ MEN1 O00255 4/20 0.61
▸ ALDH1A1 P00352 2/20 0.61
▸ RAB9A P51151 2/20 0.61
▸ KDM4E B2RXH2 1/20 0.61
▸ HPGD P15428 1/20 0.61
▸ CYP2C19 P33261 1/20 0.61
▸ MAPT P10636 2/20 0.59
▸ CA12 O43570 2/20 0.59
▸ CA1 P00915 2/20 0.59
▸ CA2 P00918 2/20 0.59
▸ CA9 Q16790 2/20 0.59
▸ BRD4 O60885 1/20 0.59
▸ NR1I2 O75469 1/20 0.59
▸ MB P02144 1/20 0.59
▸ CYP1A1 P04798 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL861674 0.83 SMN1; SMN2 (0.84) TDP1SMN1; SMN2HTTL3MBTL1KMT2A
SCHEMBL28330756 0.81 SMN1; SMN2 (0.59) TDP1SMN1; SMN2HTTL3MBTL1KMT2A
SCHEMBL61417 0.79 TDP1 (1.00) TDP1SMN1; SMN2HTTL3MBTL1KMT2A
SCHEMBL599684 0.78 KMT2A (0.73) TDP1SMN1; SMN2HTTL3MBTL1KMT2A
SCHEMBL5640360 0.78 MAPT (0.50) TDP1SMN1; SMN2HTTL3MBTL1KMT2A
SCHEMBL7789704 0.78 MEN1 (0.32) TDP1KMT2AMEN1
SCHEMBL9490753 0.78 GAA (0.58) SMN1; SMN2HTTKMT2AMEN1ALDH1A1
SCHEMBL1176999 0.78 L3MBTL1 (0.73) SMN1; SMN2HTTL3MBTL1KMT2AMEN1
SCHEMBL3818831 0.77 SMN1; SMN2 (1.00) TDP1SMN1; SMN2HTTL3MBTL1KMT2A
SCHEMBL11158565 0.77 MAPT (0.83) TDP1SMN1; SMN2HTTL3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011094890-A1 PHENYLALANINE DERIVATIVES AND THEIR USE AS NON-PEPTIDE GLP-1 RECEPTOR MODULATORS ARGUSINA INC. (US) 2011-08-11 — — WO disclosed
US-20110045397-A1 CHARGE CONTROL AGENT AND RELATED ART KURODA KAZUYOSHI 2011-02-24 — — US disclosed
CN-100549847-C Charge control agent and correlation technique thereof ORIENT CHEMICAL IND (JP) 2009-10-14 — — CN disclosed
US-20090053641-A1 CHARGE CONTROL AGENT AND RELATED ART ORIENT CHEMICAL INDUSTRIES, LTD. (JP) 2009-02-26 — — US disclosed
EP-1862860-A1 CHARGE CONTROL AGENT AND RELATED TECHNIQUE Orient Chemical Industries, Ltd. (JP) 2007-12-05 — — EP disclosed
CN-101044436-A Charge control agent and related technique ORIENT CHEMICAL IND (JP) 2007-09-26 — — CN disclosed
US-6613814-B2 Water-dispersed particles of an oil-soluble pyrrolotriazol-azomethine dyes and an oil-soluble polymer; reproduction, especially cyan color; waterproofing; colorfastness; storage stability; antifouling agents; paper FUJI PHOTO FILM CO., LTD. (JP) 2003-09-02 — — US disclosed
US-20010020055-A1 Coloring composition, ink for ink jet, and ink jet recording method FUJIFILM CORPORATION (JP) 2001-09-06 — — US disclosed
EP-0903350-A1 Pyrrolotriazole derivative FUJI PHOTO FILM CO., LTD. (JP) 1999-03-24 — — EP disclosed
EP-0423796-B1 Thermal transfer dye donating materials FUJI PHOTO FILM CO LTD (JP) 1996-05-29 — — EP disclosed
US-5227359-A Pyrazoloazole dyes FUJI PHOTO FILM CO., LTD. (JP) 1993-07-13 — — US disclosed
US-5210200-A Fast to heat and light FUJI PHOTO FILM CO., LTD. (JP) 1993-05-11 — — US disclosed
EP-0518238-A1 Pyrrolotriazole derivative FUJI PHOTO FILM CO., LTD. (JP) 1992-12-16 — — EP disclosed
US-5128312-A Thermal transfer dye donating material FUJI PHOTO FILM CO., LTD. (JP) 1992-07-07 — — US disclosed
EP-0423796-A1 Thermal transfer dye donating materials FUJI PHOTO FILM CO., LTD. (JP) 1991-04-24 — — EP disclosed
US-4975409-A Ketone imine dyes; colorfastness; copies FUJI PHOTO FILM CO., LTD. (JP) 1990-12-04 — — US disclosed
US-4140860-A BACTERICIDES STERLING DRUG INC. (US) 1979-02-20 — — US disclosed
US-4119668-A ANTIBACTERIAL AGENTS STERLING DRUG INC. (US) 1978-10-10 — — US disclosed
US-4085144-A ANTIBACTERIAL STERLING DRUG INC. (US) 1978-04-18 — — US disclosed
US-4022833-A ANTIBACTERIAL AGENTS STERLING DRUG INC. (US) 1977-05-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090053641-A1 CHARGE CONTROL AGENT AND RELATED ART H1-4, CECR2, DOT1L TDP1 2528/4885SMN1; SMN2 2533/4885HTT 755/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback